Sortilin levels are associated with peripheral arterial disease in type 2 diabetic subjects
Authors:
- Federico BiscettiFederico Biscetti
- Nicola BonadiaNBNicola Bonadia
- Francesco SantiniFSFrancesco Santini
- Flavia AngeliniFAFlavia Angelini
- Elisabetta NardellaENElisabetta Nardella
- Dario PitoccoDPDario Pitocco
- Angelo SantoliquidoASAngelo Santoliquido
- Marco FilipponiMFMarco Filipponi
- Raffaele LandolfiRLRaffaele Landolfi
- Andrea FlexAFAndrea Flex
Open Access
- 11 January 2019
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 18 (1) , 1-8
Abstract
Sortilin is a 95-kDa protein which has recently been linked to circulating cholesterol concentration and lifetime risk of developing significant atherosclerotic disease. Sortilin is found inside different cell types and circulating in blood. Higher circulating sortilin concentration has been found in patients with coronary atherosclerosis compared to control subjects. Sortilin concentration is influenced by statin therapy. We enrolled statin-naïve subjects with type 2 diabetes mellitus and we performed a cross-sectional study to evaluate the association between sortilin levels and the presence of clinically significant lower limb peripheral artery disease (PAD) in a population of statin-free diabetic subjects. Out of the 154 patients enrolled in our study, 80 patients were free from PAD, while 74 had clinically significant PAD. Sortilin concentration was significantly higher in the latter group compared to the former (1.61 ± 0.54 ng/mL versus 0.67 ± 0.30 ng/mL, P < 0.01) and there was a trend toward increased sortilin levels as disease severity increased. The association of sortilin levels with PAD remained after adjusting for major risk factors in a multivariate analysis. We showed that sortilin is significantly and independently associated with the presence of lower limb PAD in a statin-free diabetic population and it may be a promising marker for clinically significant atherosclerosis of the lower limbs. Further studies are needed to confirm this finding and to evaluate its clinical usefulness.Keywords
This publication has 49 references indexed in Scilit:
- Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolismJournal of Clinical Investigation, 2012
- Large-scale association analysis identifies 13 new susceptibility loci for coronary artery diseaseNature Genetics, 2011
- Biological, clinical and population relevance of 95 loci for blood lipidsNature, 2010
- From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locusNature, 2010
- Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variantsNature Genetics, 2009
- Common variants at 30 loci contribute to polygenic dyslipidemiaNature Genetics, 2008
- Loci influencing lipid levels and coronary heart disease risk in 16 European population cohortsNature Genetics, 2008
- Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humansNature Genetics, 2008
- Genome-wide Association Study Identifies Genes for Biomarkers of Cardiovascular Disease: Serum Urate and DyslipidemiaThe American Journal of Human Genetics, 2008
- Genomewide Association Analysis of Coronary Artery DiseaseNew England Journal of Medicine, 2007